WallStSmart

Acacia Research Corporation (ACTG) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target

Acacia Research Corporation stock (ACTG) is currently trading at $5.04. Acacia Research Corporation PE ratio is 22.05. Acacia Research Corporation PS ratio (Price-to-Sales) is 1.64. Analyst consensus price target for ACTG is $6.00. WallStSmart rates ACTG as Sell.

  • ACTG PE ratio analysis and historical PE chart
  • ACTG PS ratio (Price-to-Sales) history and trend
  • ACTG intrinsic value — DCF, Graham Number, EPV models
  • ACTG stock price prediction 2025 2026 2027 2028 2029 2030
  • ACTG fair value vs current price
  • ACTG insider transactions and insider buying
  • Is ACTG undervalued or overvalued?
  • Acacia Research Corporation financial analysis — revenue, earnings, cash flow
  • ACTG Piotroski F-Score and Altman Z-Score
  • ACTG analyst price target and Smart Rating
ACTG

Acacia Research Corporation

NASDAQINDUSTRIALS
$5.04
$0.13 (2.65%)
52W$2.70
$5.21
Target$6.00+19.0%

📊 No data available

Try selecting a different time range

IV

ACTG Intrinsic Value Analysis for Value Investors

Benjamin Graham Formula · Acacia Research Corporation (ACTG)

Margin of Safety
-170.7%
Significantly Overvalued
ACTG Fair Value
$1.50
Graham Formula
Current Price
$5.04
$3.54 above fair value
Undervalued
Fair: $1.50
Overvalued
Price $5.04
Graham IV $1.50
Analyst $6.00

ACTG trades 171% above its Graham fair value of $1.50, indicating the stock may be overvalued at current levels.

Based on Benjamin Graham Formula. Growth rate capped at 25%. For informational purposes only. Not financial advice.

WallStSmart

Smart Analysis

Acacia Research Corporation (ACTG) · 10 metrics scored

Smart Score

45
out of 100
Grade: D
Hold
Investment Rating

Category Performance

WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.

Investment Thesis

Strong fundamentals in price/sales, price/book, institutional own.. Concerns around return on equity and operating margin. Mixed signals suggest waiting for clearer direction before acting.

Acacia Research Corporation (ACTG) Key Strengths (3)

Avg Score: 9.3/10
Price/BookValuation
0.8610/10

Trading below book value, meaning the market prices it less than net assets

Institutional Own.Quality
88.47%10/10

88.47% of shares held by major funds and institutions

Price/SalesValuation
1.648/10

Paying $1.64 for every $1 of annual revenue

Supporting Valuation Data

Price/Sales (TTM)
1.64
Undervalued
EV/Revenue
0.742
Undervalued
ACTG Target Price
$6
44% Upside

Acacia Research Corporation (ACTG) Areas to Watch (7)

Avg Score: 2.3/10
Operating MarginProfitability
-26.10%0/10

Losing money on operations

EPS GrowthGrowth
-97.50%0/10

Earnings declining -97.50%, profits shrinking

Return on EquityProfitability
4.31%1/10

Very low returns on shareholder equity

Revenue GrowthGrowth
2.60%2/10

Revenue growing slowly at 2.60% annually

PEG RatioValuation
2.374/10

Paying a premium for growth, expensive relative to earnings expansion

Profit MarginProfitability
7.60%4/10

Thin profit margins with limited profitability

Market CapQuality
$468M5/10

Small-cap company with higher risk but more growth potential

Supporting Valuation Data

Forward P/E
47.39
Expensive

Acacia Research Corporation (ACTG) Detailed Analysis Report

Overall Assessment

This company scores 45/100 in our Smart Analysis, earning a D grade. Out of 10 metrics analyzed, 3 register as strengths (avg 9.3/10) while 7 fall into concern territory (avg 2.3/10). The category breakdown reveals uneven performance, with some areas requiring attention.

The Bull Case

The strongest argument centers on Price/Book, Institutional Own., Price/Sales. Valuation metrics including Price/Sales (1.64), Price/Book (0.86) suggest the stock is attractively priced.

The Bear Case

The primary concerns are Operating Margin, EPS Growth, Return on Equity. Some valuation metrics including PEG Ratio (2.37) suggest expensive pricing. Growth concerns include Revenue Growth at 2.60%, EPS Growth at -97.50%, which may limit upside. Profitability pressure is visible in Return on Equity at 4.31%, Operating Margin at -26.10%, Profit Margin at 7.60%.

Key Dynamics to Monitor

Three factors to monitor going forward. First, whether Operating Margin improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at 4.31% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at 2.60% needing to reaccelerate.

Risk Considerations

Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.

Bottom Line

Fundamental challenges outweigh strengths at current levels. Operating Margin and EPS Growth are the primary drags. Consider waiting for meaningful improvement before committing capital.

Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.

ACTG Price-to-Sales(PS) Ratio Chart

Historical valuation based on market cap ÷ trailing 12-month revenue

ACTG's Price-to-Sales ratio of 1.64x trades at a deep discount to its historical average of 16.19x (2th percentile). The current valuation is 98% below its historical high of 73.77x set in Nov 2006, and 17% above its historical low of 1.4x in Mar 2026. Over the past 12 months, the PS ratio has expanded from ~1.4x, reflecting growing market expectations outpacing revenue growth.

Compare ACTG with Competitors

Top BUSINESS EQUIPMENT & SUPPLIES stocks by market cap

Compare any two stocks →

WallStSmart Analysis Synopsis

Data-driven financial summary for Acacia Research Corporation (ACTG) · INDUSTRIALSBUSINESS EQUIPMENT & SUPPLIES

The Big Picture

Acacia Research Corporation operates as a stable business with moderate growth and solid fundamentals. Revenue reached 285M with 3% growth year-over-year. Profit margins are thin at 7.6%, typical for companies in this phase that are reinvesting heavily in growth.

Key Findings

Cash Flow Positive

Generating 7M in free cash flow and 13M in operating cash flow. Earnings are translating into actual cash generation.

Low Return on Equity

ROE of 4.3% suggests the company isn't efficiently converting equity into profits.

What to Watch Next

Margin expansion: can Acacia Research Corporation push profit margins above 15% as the business scales?

Sector dynamics: monitor BUSINESS EQUIPMENT & SUPPLIES industry trends, competitive moves, and regulatory changes that could impact Acacia Research Corporation.

Bottom Line

Acacia Research Corporation offers stability with moderate growth and solid fundamentals. The valuation may present an opportunity for patient investors, though limited growth means returns will likely come from dividends and modest capital appreciation rather than explosive gains.

This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.

Insider Transactions

Loading insider activity...

About Acacia Research Corporation(ACTG)

Exchange

NASDAQ

Sector

INDUSTRIALS

Industry

BUSINESS EQUIPMENT & SUPPLIES

Country

USA

Acacia Research Corporation intends to acquire undervalued businesses primarily in the technology, life sciences, industry and financial services segments in the United States. The company is headquartered in New York, New York.